Nikolay Delev

Nikolay Delev, MD, has extensive experience in the medical field, particularly in rheumatology and clinical development. They served as the Executive Medical Director and Clinical Development Program Lead at Bristol Myers Squibb from 2019 to 2023. Prior to that, they held roles at Celgene and Novartis, contributing significantly to immunology and inflammation research. Their educational background includes a Rheumatology Post-Doctoral Fellowship from The Johns Hopkins University and an MD from Medicinski universitet - Sofia. Currently, they are the Vice President, Global Clinical Strategy Lead at argenx, a position they began in 2025.